Will Codiak BioSciences Inc (CDAK) Stay at the Bottom of the Healthcare Sector?

Thursday, March 30, 2023 11:34 AM | InvestorsObserver Analysts

Mentioned in this article

Will Codiak BioSciences Inc (CDAK) Stay at the Bottom of the Healthcare Sector?

Codiak BioSciences Inc (CDAK) is near the bottom in its sector according to InvestorsObserver. CDAK gets an overall rating of 1. That means it scores higher than 1% of stocks. Codiak BioSciences Inc gets a 26 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

CDAK has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on CDAK!

See Full CDAK Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Codiak BioSciences Inc Stock Today?

Codiak BioSciences Inc (CDAK) stock has fallen -16.9% while the S&P 500 is up 0.53% as of 11:33 AM on Thursday, Mar 30. CDAK is lower by -$0.04 from the previous closing price of $0.21 on volume of 3,474,683 shares. Over the past year the S&P 500 is down -12.03% while CDAK is lower by -97.32%. CDAK lost -$0.68 per share the over the last 12 months. Click Here to get the full Stock Report for Codiak BioSciences Inc stock.